United States Business News API

{
    "totalArticles": 329018,
    "articles": [
        {
            "id": "8acbb75a28b25de08f3370653163633c",
            "title": "Stock Market Today: Dow Firm As Pharma Stocks Shine; Nvidia Nears Record Highs",
            "description": "Stock Market Today: The Dow Jones index is steady Monday following the latest U.S.-Iran news. Nvidia stock moves toward record highs.",
            "content": "Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. The information has been obtained from sources we ... [1013 chars]",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp500-nasdaq-iran-news-nvidia-stock-nvda/",
            "image": "https://www.investors.com/wp-content/uploads/2019/10/stock-wall-street-flags-adobe.jpg",
            "publishedAt": "2026-04-27T14:26:00Z",
            "lang": "en",
            "source": {
                "id": "b5fd7d235a4765231123b8f22bcf428a",
                "name": "Investor's Business Daily",
                "url": "https://www.investors.com"
            }
        },
        {
            "id": "d26cae5cca28f1ed50d6e1ecaa186c53",
            "title": "OpenAI could be making a phone with AI agents replacing apps",
            "description": "The phone could go in mass production in 2028, an analyst says.",
            "content": "There have been plenty of rumors about OpenAI’s hardware plans, which involve launching a pair of earbuds. A new note from industry analyst Ming-Chi Kuo suggests that the AI company might be working on a phone in collaboration with MediaTek, Qualcomm... [1859 chars]",
            "url": "https://techcrunch.com/2026/04/27/openai-could-be-making-a-phone-with-ai-agents-replacing-apps/",
            "image": "https://techcrunch.com/wp-content/uploads/2025/04/GettyImages-2206295463.jpg?resize=1200,800",
            "publishedAt": "2026-04-27T13:08:59Z",
            "lang": "en",
            "source": {
                "id": "307ab9190988e16f56f3e028e3237a90",
                "name": "TechCrunch",
                "url": "https://techcrunch.com"
            }
        },
        {
            "id": "319a051a0f6ef2ee0e23892ca70b84fd",
            "title": "Oruka Therapeutics: How This Small Name Is Rivaling AbbVie's $18 Billion Franchise",
            "description": "Nearly two-thirds of patients who received Oruka Therapeutics' experimental psoriasis treatment had completely clear skin after 16 weeks.",
            "content": "Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. The information has been obtained from sources we ... [1013 chars]",
            "url": "https://www.investors.com/news/technology/oruka-therapeutics-psoriasis-treatment/",
            "image": "https://www.investors.com/wp-content/uploads/2017/11/Stock-drugVials-01-adobe.jpg",
            "publishedAt": "2026-04-27T12:40:00Z",
            "lang": "en",
            "source": {
                "id": "b5fd7d235a4765231123b8f22bcf428a",
                "name": "Investor's Business Daily",
                "url": "https://www.investors.com"
            }
        }
    ]
}